IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy
Stopped The collaborating party has adjusted its R\&D strategy and terminated the study.
Conditions
- Systemic Lupus Erythematosus (SLE)
- ANCA Associated Vasculitis (AAV)
- Idiopathic Inflammatory Myopathy (IIM)
Interventions
- DRUG: IMPT-514 CART Cell Injection
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School